Richard Close
Stock Analyst at Canaccord Genuity
(1.27)
# 3,390
Out of 4,842 analysts
141
Total ratings
31.43%
Success rate
-11.46%
Average return
Main Sectors:
Stocks Rated by Richard Close
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DOCS Doximity | Maintains: Hold | $71 → $50 | $52.45 | -4.67% | 10 | May 16, 2025 | |
HSTM HealthStream | Maintains: Hold | $30 → $29 | $28.07 | +3.31% | 7 | May 15, 2025 | |
QIPT Quipt Home Medical | Downgrades: Hold | $4 → $1.7 | $1.73 | -1.73% | 4 | May 13, 2025 | |
PGNY Progyny | Maintains: Hold | $23 → $21 | $21.25 | -1.18% | 7 | May 12, 2025 | |
DCGO DocGo | Downgrades: Hold | $5 → $1.45 | $1.36 | +6.62% | 6 | May 12, 2025 | |
PINC Premier | Maintains: Hold | $19 → $22 | $22.88 | -3.85% | 13 | May 8, 2025 | |
HCAT Health Catalyst | Maintains: Buy | $10 → $9 | $3.69 | +144.23% | 8 | May 8, 2025 | |
WAY Waystar Holding | Maintains: Buy | $50 → $47 | $38.40 | +22.40% | 5 | May 1, 2025 | |
TDOC Teladoc Health | Maintains: Buy | $14 → $12 | $7.14 | +68.07% | 16 | May 1, 2025 | |
LFST LifeStance Health Group | Initiates: Buy | $8 | $5.97 | +34.00% | 1 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.21 | +55.76% | 1 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $35 | $23.88 | +46.57% | 9 | Mar 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.2 → $4.5 | $3.16 | +42.41% | 3 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $30 | $23.37 | +28.37% | 8 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $9.16 | +52.84% | 7 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $16 | $7.67 | +108.60% | 11 | Jan 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $120.36 | +0.53% | 3 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1,170 → $225 | $1.57 | +14,231.21% | 6 | Mar 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $31.92 | -24.81% | 3 | Aug 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $72.64 | +30.78% | 9 | Apr 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $28.63 | -38.00% | 4 | Dec 20, 2018 |
Doximity
May 16, 2025
Maintains: Hold
Price Target: $71 → $50
Current: $52.45
Upside: -4.67%
HealthStream
May 15, 2025
Maintains: Hold
Price Target: $30 → $29
Current: $28.07
Upside: +3.31%
Quipt Home Medical
May 13, 2025
Downgrades: Hold
Price Target: $4 → $1.7
Current: $1.73
Upside: -1.73%
Progyny
May 12, 2025
Maintains: Hold
Price Target: $23 → $21
Current: $21.25
Upside: -1.18%
DocGo
May 12, 2025
Downgrades: Hold
Price Target: $5 → $1.45
Current: $1.36
Upside: +6.62%
Premier
May 8, 2025
Maintains: Hold
Price Target: $19 → $22
Current: $22.88
Upside: -3.85%
Health Catalyst
May 8, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.69
Upside: +144.23%
Waystar Holding
May 1, 2025
Maintains: Buy
Price Target: $50 → $47
Current: $38.40
Upside: +22.40%
Teladoc Health
May 1, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $7.14
Upside: +68.07%
LifeStance Health Group
Apr 3, 2025
Initiates: Buy
Price Target: $8
Current: $5.97
Upside: +34.00%
Apr 3, 2025
Initiates: Buy
Price Target: $5
Current: $3.21
Upside: +55.76%
Mar 13, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $23.88
Upside: +46.57%
Mar 3, 2025
Maintains: Buy
Price Target: $4.2 → $4.5
Current: $3.16
Upside: +42.41%
Feb 28, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $23.37
Upside: +28.37%
Feb 26, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $9.16
Upside: +52.84%
Jan 23, 2025
Maintains: Buy
Price Target: $23 → $16
Current: $7.67
Upside: +108.60%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $120.36
Upside: +0.53%
Mar 9, 2022
Maintains: Hold
Price Target: $1,170 → $225
Current: $1.57
Upside: +14,231.21%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $31.92
Upside: -24.81%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $72.64
Upside: +30.78%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $28.63
Upside: -38.00%